February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla: Capturing Opportunity in a Contrarian Market
Microsoft: Resilient Amid Sell-Off, 'Buy' Stance Reaffirmed
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Qualigen Therapeutics (QLGN) stock forecast for 2026
Updated: March 4, 2025 (22:56)
Sector: HealthcareThe share price of Qualigen Therapeutics, Inc. (QLGN) now
50/200 Day Moving Average: $3.799 / $7.83
This figure corresponds to the Average Price over the previous 50/200 days. For Qualigen Therapeutics stocks, the 50-day moving average is the resistance level today.
For Qualigen Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Qualigen Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Qualigen Therapeutics stock price in 2026. How much will one Qualigen Therapeutics share be worth in 2026? Is it worth taking profit / loss on QLGN stock now or waiting? What are analysts' forecasts for Qualigen Therapeutics stock?
We forecast Qualigen Therapeutics stock performance using neural networks based on historical data on QLGN stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Qualigen Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Qualigen Therapeutics analysts is $5. Today 200 Day Moving Average is the resistance level (7.83 $). 50 Day Moving Average is the resistance level (3.799 $).
Historical and forecast chart of Qualigen Therapeutics, Inc. stock
The chart below shows the historical price of Qualigen Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the QLGN stock price can be found in the table below.
Qualigen Therapeutics, Inc., formerly Ritter Pharmaceuticals, Inc., is a biotech company. The company is focused on the development and commercialization of therapeutic drugs for the treatment of cancer and infectious diseases, as well as the development of its FastPack diagnostic platform. Its pipeline includes AS1411, Aptamer Linked Anti Nucleolin (ALAN), Aptamer Linked Anti Nucleolin – Contrast Enhancement (ALAN-CE), Aptamer Linked Anti Nucleolin – Radiation Enhancement (ALAN-RE), Selective Target Antigen Removal System (STARS) and RAS- F. The FastPack System is an immunoassay system that consists of a FastPack analyzer and a FastPack test bag — a disposable, disposable foil bag containing FastPack reagent. Subsidiary of the company – Qualigen, Inc.
Qualigen Therapeutics (QLGN) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.01 | 1.76 | 2.10 | 16.17 % |
| Feb | 2.14 | 2.00 | 2.42 | 17.44 % |
| Mar | 2.05 | 1.81 | 2.36 | 23.00 % |
| Apr | 1.89 | 1.70 | 2.15 | 20.93 % |
| May | 1.75 | 1.54 | 1.90 | 18.90 % |
| Jun | 2.04 | 1.75 | 2.35 | 25.32 % |
| Jul | 1.95 | 1.68 | 2.13 | 21.34 % |
| Aug | 1.93 | 1.76 | 2.09 | 15.78 % |
| Sep | 2.27 | 2.02 | 2.39 | 15.49 % |
| Oct | 2.38 | 2.23 | 2.58 | 13.65 % |
| Nov | 2.11 | 2.01 | 2.41 | 16.30 % |
| Dec | 1.82 | 1.71 | 2.03 | 15.86 % |
Qualigen Therapeutics information and performance
1880 CENTURY PARK EAST, SUITE 1000, LOS ANGELES, CA, US
Market capitalization of the Qualigen Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of QLGN shares in the company outstanding by the market price of one share.
EBITDA of Qualigen Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Qualigen Therapeutics price target for 2026 by month
Target values for the price of one Qualigen Therapeutics share for Jan 2026.
In Jan, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.173% volatility is expected.
Pessimistic target level: 1.76
Optimistic target level: 2.10
Target values for the price of one Qualigen Therapeutics share for Feb 2026.
In Feb, the Positive dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 17.440% volatility is expected.
Pessimistic target level: 2.00
Optimistic target level: 2.42
Target values for the price of one Qualigen Therapeutics share for Mar 2026.
In Mar, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.001% volatility is expected.
Pessimistic target level: 1.81
Optimistic target level: 2.36
Target values for the price of one Qualigen Therapeutics share for Apr 2026.
In Apr, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 20.927% volatility is expected.
Pessimistic target level: 1.70
Optimistic target level: 2.15
Target values for the price of one Qualigen Therapeutics share for May 2026.
In May, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.904% volatility is expected.
Pessimistic target level: 1.54
Optimistic target level: 1.90
Target values for the price of one Qualigen Therapeutics share for Jun 2026.
In Jun, the Positive dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 25.318% volatility is expected.
Pessimistic target level: 1.75
Optimistic target level: 2.35
Target values for the price of one Qualigen Therapeutics share for Jul 2026.
In Jul, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.342% volatility is expected.
Pessimistic target level: 1.68
Optimistic target level: 2.13
Target values for the price of one Qualigen Therapeutics share for Aug 2026.
In Aug, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.781% volatility is expected.
Pessimistic target level: 1.76
Optimistic target level: 2.09
Target values for the price of one Qualigen Therapeutics share for Sep 2026.
In Sep, the Positive dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.487% volatility is expected.
Pessimistic target level: 2.02
Optimistic target level: 2.39
Target values for the price of one Qualigen Therapeutics share for Oct 2026.
In Oct, the Positive dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 13.653% volatility is expected.
Pessimistic target level: 2.23
Optimistic target level: 2.58
Target values for the price of one Qualigen Therapeutics share for Nov 2026.
In Nov, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.298% volatility is expected.
Pessimistic target level: 2.01
Optimistic target level: 2.41
Target values for the price of one Qualigen Therapeutics share for Dec 2026.
In Dec, the Negative dynamics for Qualigen Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.862% volatility is expected.
Pessimistic target level: 1.71
Optimistic target level: 2.03
Qualigen Therapeutics (QLGN) stock dividend
Qualigen Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 05/26/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
